Benten Biotech constantly advances in several treatment and diagnostic projects based on recombinant single-domain antibodies and develop a new generation of in vitro assays for the quantification of antigens based on single-domain antibodies. Benten Biotech grows stronger in the quality control of veterinary biological products: we provide standardized reagents to various countries and carry out outsourced potency tests of vaccines, and also transfer turnkey production technologies and train the quality control teams of other companies.